Related Experiment Video
Updated: Dec 23, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left Atrial Appendage Occlusion in Patients With Thrombus in Left Atrial Appendage
Levent Sahiner, Cem Coteli1, Ergun Baris Kaya
1Ankara City Hospital, Cardiology, Üniversiteler Mahallesi Bilkent Cad. No:1 Çankaya/ANKARA, Ankara, Çankaya 06800, Turkey. cemcoteli@hacettepe.edu.tr.
Insights
Left atrial appendage (LAA) occlusion is a safe and effective treatment for patients with atrial fibrillation (AF) and LAA thrombus. This procedure offers an alternative for those who cannot use oral anticoagulation, demonstrating no major adverse events during follow-up.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Left atrial appendage (LAA) occlusion is an alternative for thromboembolic prevention in atrial fibrillation (AF) patients unsuitable for oral anticoagulation (OAC).
- Traditionally, LAA thrombus was a contraindication for LAA occlusion, but recent evidence suggests it may be an indication in cases of resistant thrombus formation.
- This study investigates the safety and efficacy of LAA occlusion in patients with pre-existing LAA thrombus.
Purpose of the Study:
- To evaluate the safety and efficacy of percutaneous LAA occlusion in patients with LAA thrombus.
- To assess the outcomes of LAA occlusion using the Amplatzer Amulet device in this specific patient population.
Main Methods:
- A single-center study enrolled 12 non-valvular AF patients with LAA thrombus.
- Patients underwent successful LAA occlusion with the Amplatzer Amulet device.
- Follow-up included transesophageal echocardiography (TEE) at 1 and 6 months, with a median follow-up of 12 months.
Main Results:
- All 12 patients underwent successful LAA occlusion without significant periprocedural adverse events.
- No cardiovascular or all-cause mortality, ischemic cerebrovascular events, heart failure worsening, or major bleeding occurred during follow-up.
- Transesophageal echocardiography revealed no device-related thrombus formation.
Conclusions:
- Percutaneous LAA closure is a viable therapeutic option for patients with resistant LAA thrombus.
- LAA occlusion demonstrates safety and efficacy in AF patients with LAA thrombus, even in the presence of high thromboembolic risk scores.
Background:
Atrial appendage (LAA) occlusion is a therapeutic option for thromboembolic prevention in atrial fibrillation (AF) patients who have contraindications to oral anticoagulation (OAC) or high risk of bleeding. Traditionally, thrombus in the LAA has been considered a contraindication for LAA occlusion. Recently, resistant thrombus formation in patients using OACs was suggested as an indication for LAA occlusion.
Methods And Results:
In this single-center study, we evaluated the safety and efficacy of LAA occlusion in patients with a thrombus in the LAA. Twelve non-valvular AF patients who had a thrombus in the LAA were enrolled. The mean age was 71.8 years (range, 62-83 years). Permanent AF was present in all patients. Mean CHA2DS2-VASc score was 4.9 (range, 2-8) and mean HAS-BLED score was 4.8 (range, 3-6). Thrombi in the LAA were classified as type 1 (proximal to mid) and type 2 (distal) in 3 and 9 patients, respectively. Median follow-up duration was 12 months (interquartile range, 6-24 months). LAA occlusion was performed successfully with Amplatzer Amulet device without any significant periprocedural adverse events in all 12 patients. Transesophageal echocardiography (TEE) was performed at 1 and 6 months post procedure. Cardiovascular and all-cause mortality, significant ischemic cerebrovascular events, worsening heart failure, and major bleeding events did not occur during follow-up. Device-related thrombus was not observed with TEE in any patient.
Conclusion:
Our study showed that percutaneous LAA closure could be a therapeutic option for patients with resistant LAA thrombus.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization III: Left Heart Catheterization

